Publication Information

{'id': 'https://openalex.org/W1919558603', 'doi': 'https://doi.org/10.1111/j.1365-2710.2012.01342.x', 'title': 'Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes', 'display_name': 'Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes', 'publication_year': 2012, 'publication_date': '2012-03-21', 'ids': {'openalex': 'https://openalex.org/W1919558603', 'doi': 'https://doi.org/10.1111/j.1365-2710.2012.01342.x', 'mag': '1919558603', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/22436069'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/j.1365-2710.2012.01342.x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S156693432', 'display_name': 'Journal of Clinical Pharmacy and Therapeutics', 'issn_l': '0269-4727', 'issn': ['0269-4727', '1365-2710'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5090784160', 'display_name': 'Susan Cornell', 'orcid': 'https://orcid.org/0000-0002-9934-035X'}, 'institutions': [{'id': 'https://openalex.org/I128902783', 'display_name': 'Midwestern University', 'ror': 'https://ror.org/046yatd98', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I128902783']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'S. Cornell', 'raw_affiliation_strings': ['Chicago College of Pharmacy, Midwestern University, Downers Grove, IL 60515, USA'], 'affiliations': [{'raw_affiliation_string': 'Chicago College of Pharmacy, Midwestern University, Downers Grove, IL 60515, USA', 'institution_ids': ['https://openalex.org/I128902783']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5090784160'], 'corresponding_institution_ids': ['https://openalex.org/I128902783'], 'apc_list': {'value': 2500, 'currency': 'USD', 'value_usd': 2500, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 1.031, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 40, 'citation_normalized_percentile': {'value': 0.526316, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 94, 'max': 95}, 'biblio': {'volume': '37', 'issue': '5', 'first_page': '510', 'last_page': '524'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10560', 'display_name': 'Diabetes Management and Research', 'score': 0.9946, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12539', 'display_name': 'Pharmacology and Obesity Treatment', 'score': 0.9926, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/incretin', 'display_name': 'Incretin', 'score': 0.94390976}, {'id': 'https://openalex.org/keywords/vildagliptin', 'display_name': 'Vildagliptin', 'score': 0.5201212}, {'id': 'https://openalex.org/keywords/pharmacotherapy', 'display_name': 'Pharmacotherapy', 'score': 0.4709108}, {'id': 'https://openalex.org/keywords/lixisenatide', 'display_name': 'Lixisenatide', 'score': 0.4650361}], 'concepts': [{'id': 'https://openalex.org/C2780533449', 'wikidata': 'https://www.wikidata.org/wiki/Q417762', 'display_name': 'Exenatide', 'level': 4, 'score': 0.9599743}, {'id': 'https://openalex.org/C2778881409', 'wikidata': 'https://www.wikidata.org/wiki/Q1420402', 'display_name': 'Incretin', 'level': 4, 'score': 0.94390976}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8948688}, {'id': 'https://openalex.org/C2781308992', 'wikidata': 'https://www.wikidata.org/wiki/Q2526479', 'display_name': 'Liraglutide', 'level': 4, 'score': 0.7466035}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.74031496}, {'id': 'https://openalex.org/C156490143', 'wikidata': 'https://www.wikidata.org/wiki/Q412214', 'display_name': 'Dipeptidyl peptidase-4', 'level': 4, 'score': 0.5531885}, {'id': 'https://openalex.org/C2776453732', 'wikidata': 'https://www.wikidata.org/wiki/Q421042', 'display_name': 'Vildagliptin', 'level': 4, 'score': 0.5201212}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.49969053}, {'id': 'https://openalex.org/C185280430', 'wikidata': 'https://www.wikidata.org/wiki/Q14909910', 'display_name': 'Glucagon-like peptide 1 receptor', 'level': 4, 'score': 0.48714778}, {'id': 'https://openalex.org/C2779284873', 'wikidata': 'https://www.wikidata.org/wiki/Q419832', 'display_name': 'Sitagliptin', 'level': 4, 'score': 0.48129335}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.4808715}, {'id': 'https://openalex.org/C500440147', 'wikidata': 'https://www.wikidata.org/wiki/Q701216', 'display_name': 'Pharmacotherapy', 'level': 2, 'score': 0.4709108}, {'id': 'https://openalex.org/C2776442814', 'wikidata': 'https://www.wikidata.org/wiki/Q6659956', 'display_name': 'Lixisenatide', 'level': 5, 'score': 0.4650361}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.45750642}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.42051268}, {'id': 'https://openalex.org/C2776398474', 'wikidata': 'https://www.wikidata.org/wiki/Q424611', 'display_name': 'Glucagon-like peptide-1', 'level': 4, 'score': 0.4202322}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.32668877}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.18174025}, {'id': 'https://openalex.org/C2778938600', 'wikidata': 'https://www.wikidata.org/wiki/Q389934', 'display_name': 'Agonist', 'level': 3, 'score': 0.11654356}], 'mesh': [{'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D054795', 'descriptor_name': 'Incretins', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018027', 'descriptor_name': 'Receptors, Glucagon', 'qualifier_ui': 'Q000819', 'qualifier_name': 'agonists', 'is_major_topic': True}, {'descriptor_ui': 'D001786', 'descriptor_name': 'Blood Glucose', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001786', 'descriptor_name': 'Blood Glucose', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000067757', 'descriptor_name': 'Glucagon-Like Peptide-1 Receptor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054795', 'descriptor_name': 'Incretins', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D054795', 'descriptor_name': 'Incretins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016032', 'descriptor_name': 'Randomized Controlled Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018027', 'descriptor_name': 'Receptors, Glucagon', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D018027', 'descriptor_name': 'Receptors, Glucagon', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/j.1365-2710.2012.01342.x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S156693432', 'display_name': 'Journal of Clinical Pharmacy and Therapeutics', 'issn_l': '0269-4727', 'issn': ['0269-4727', '1365-2710'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/22436069', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.8}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 91, 'referenced_works': ['https://openalex.org/W1518543897', 'https://openalex.org/W1532170875', 'https://openalex.org/W1547073044', 'https://openalex.org/W1559082056', 'https://openalex.org/W1755903692', 'https://openalex.org/W1966469183', 'https://openalex.org/W1970125713', 'https://openalex.org/W1972308825', 'https://openalex.org/W1975591028', 'https://openalex.org/W1977102586', 'https://openalex.org/W1981183973', 'https://openalex.org/W1981555824', 'https://openalex.org/W1984805407', 'https://openalex.org/W1984805650', 'https://openalex.org/W1986331352', 'https://openalex.org/W1992868203', 'https://openalex.org/W1994743271', 'https://openalex.org/W2004409542', 'https://openalex.org/W2005230361', 'https://openalex.org/W2026348270', 'https://openalex.org/W2028092672', 'https://openalex.org/W2033665483', 'https://openalex.org/W2038953694', 'https://openalex.org/W2043900831', 'https://openalex.org/W2045063167', 'https://openalex.org/W2045321591', 'https://openalex.org/W2045970464', 'https://openalex.org/W2047041946', 'https://openalex.org/W2048728983', 'https://openalex.org/W2050826565', 'https://openalex.org/W2057913111', 'https://openalex.org/W2060124483', 'https://openalex.org/W2061691264', 'https://openalex.org/W2069661907', 'https://openalex.org/W2071835038', 'https://openalex.org/W2074142099', 'https://openalex.org/W2078090288', 'https://openalex.org/W2084744936', 'https://openalex.org/W2084948079', 'https://openalex.org/W2087025850', 'https://openalex.org/W2090920461', 'https://openalex.org/W2098459806', 'https://openalex.org/W2101246901', 'https://openalex.org/W2102400698', 'https://openalex.org/W2102511839', 'https://openalex.org/W2103058881', 'https://openalex.org/W2103266155', 'https://openalex.org/W2103525547', 'https://openalex.org/W2105926302', 'https://openalex.org/W2107949845', 'https://openalex.org/W2108646121', 'https://openalex.org/W2109728760', 'https://openalex.org/W2111901007', 'https://openalex.org/W2112981414', 'https://openalex.org/W2113367996', 'https://openalex.org/W2114927834', 'https://openalex.org/W2116492775', 'https://openalex.org/W2116969055', 'https://openalex.org/W2118186702', 'https://openalex.org/W2118710260', 'https://openalex.org/W2118762421', 'https://openalex.org/W2118889627', 'https://openalex.org/W2126065052', 'https://openalex.org/W2128648250', 'https://openalex.org/W2137352234', 'https://openalex.org/W2138077952', 'https://openalex.org/W2138290933', 'https://openalex.org/W2139485303', 'https://openalex.org/W2140240975', 'https://openalex.org/W2140480989', 'https://openalex.org/W2140952918', 'https://openalex.org/W2140978079', 'https://openalex.org/W2142400535', 'https://openalex.org/W2143847100', 'https://openalex.org/W2145266416', 'https://openalex.org/W2146901298', 'https://openalex.org/W2152984355', 'https://openalex.org/W2157869836', 'https://openalex.org/W2158727328', 'https://openalex.org/W2158778171', 'https://openalex.org/W2159198773', 'https://openalex.org/W2159205789', 'https://openalex.org/W2160001758', 'https://openalex.org/W2160511051', 'https://openalex.org/W2164416879', 'https://openalex.org/W2169760435', 'https://openalex.org/W2170606300', 'https://openalex.org/W2191569664', 'https://openalex.org/W2344620176', 'https://openalex.org/W2607126146', 'https://openalex.org/W3212229422'], 'related_works': ['https://openalex.org/W4251091689', 'https://openalex.org/W3114382483', 'https://openalex.org/W2976394260', 'https://openalex.org/W2963614034', 'https://openalex.org/W2808414723', 'https://openalex.org/W2592545469', 'https://openalex.org/W2277023506', 'https://openalex.org/W2035474792', 'https://openalex.org/W2031428711', 'https://openalex.org/W1885494502'], 'abstract_inverted_index': {'What': [0, 290], 'is': [1, 291], 'known': [2], 'and': [3, 12, 57, 97, 106, 112, 126, 147, 150, 164, 266, 276, 288, 293, 301, 304, 318, 322, 333], 'Objective:': [4], 'Incretin-based': [5], 'glucagon-like': [6], 'peptide-1': [7, 129], 'receptor': [8, 130], 'agonists': [9, 131], '(GLP-1': [10], 'RAs)': [11], 'dipeptidyl': [13], 'peptidase-4': [14], '(DPP-4)': [15], 'inhibitor': [16], 'therapies': [17, 31, 94, 118, 256, 332], 'provide': [18], 'glycaemic': [19, 111, 303], 'control': [20], 'with': [21, 25, 34, 73, 204, 281], 'reduced': [22], 'risks': [23], 'associated': [24, 280], 'weight': [26, 152, 248], 'gain': [27], 'or': [28, 208, 228, 240], 'hypoglycaemia.': [29], 'Incretin': [30], 'are': [32, 132, 201, 226, 238], 'compared': [33], 'their': [35, 59, 140, 175], 'mechanisms': [36, 298], 'of': [37, 68, 115, 139, 174, 263, 269, 277, 299, 342], 'action,': [38], 'effects': [39, 114, 178, 200], 'on': [40, 179], 'haemoglobin': [41], 'A1C': [42], '(HbA1C),': [43], 'fasting': [44], 'plasma': [45], 'glucose': [46, 49], '(FPG),': [47], 'post-prandial': [48], '(PPG),': [50], 'body': [51], 'weight,': [52], 'β-cell': [53, 264], 'function,': [54], 'cardiovascular': [55], 'biomarkers': [56], 'in': [58, 65, 99, 143, 220, 297, 302, 339], 'safety': [60], 'profiles': [61], 'to': [62, 121, 230, 253], 'aid': [63, 338], 'clinicians': [64], 'the': [66, 100, 242, 314, 340, 343], 'selection': [67, 341], 'individualized': [69, 348], 'pharmacotherapy': [70], 'for': [71, 80, 211, 347], 'patients': [72, 207, 215, 224], 'type': [74, 273, 282], '2': [75, 274, 283], 'diabetes.': [76], 'Methods:': [77], 'Relevant': [78], 'articles': [79], 'a': [81, 156, 185, 195], 'systematic': [82], 'review': [83], 'were': [84, 95, 123], 'identified': [85, 96], 'through': [86], 'PubMed.': [87], 'Randomized,': [88], 'head-to-head': [89], 'comparison': [90], 'studies': [91, 109], 'among': [92, 309, 330], 'incretin': [93, 117, 310, 331, 345], 'included': [98], 'review.': [101], 'Additionally,': [102], 'randomized,': [103], 'controlled': [104], 'monotherapy': [105, 157], 'combination': [107], 'therapy': [108], 'examining': [110], 'extraglycaemic': [113], 'individual': [116], 'from': [119, 247], '2007': [120], '2011': [122], 'reviewed.': [124], 'Results': [125], 'Discussion:': [127], 'Glucagon-like': [128], 'generally': [133], 'preferred': [134, 169], 'over': [135], 'DPP-4': [136, 212, 323], 'inhibitors': [137, 213], 'because': [138, 173], 'greater': [141, 151], 'effectiveness': [142], 'reducing': [144], 'HbA1C,': [145, 184, 221], 'FPG': [146], 'PPG': [148], 'excursions,': [149], 'loss': [153], 'potentiation.': [154], 'As': [155], 'option,': [158], 'longer-acting': [159], 'GLP-1': [160, 187, 236, 315, 320], 'RAs,': [161], 'including': [162], 'liraglutide': [163], 'exenatide': [165, 191], 'once-weekly,': [166], 'may': [167, 193], 'be': [168, 194], 'at': [170], 'higher': [171], 'HbA1C': [172], 'more': [176, 202], 'pronounced': [177, 203], 'FPG.': [180], 'At': [181], 'lower/near': [182], 'normal': [183], 'short-acting': [186], 'RA,': [188], 'such': [189, 285], 'as': [190, 198, 286], 'twice-daily,': [192], 'better': [196], 'choice': [197], 'its': [199], 'PPG.': [205], 'Ideal': [206], 'patient': [209, 243, 335], 'situations': [210], 'include': [214, 257], 'who': [216, 225], 'need': [217], 'minimal': [218, 258], 'reduction': [219], 'elderly': [222], 'patients,': [223], 'unwilling': [227], 'unable': [229], 'take': [231], 'an': [232], 'injectable': [233], 'agent,': [234], 'when': [235, 241], 'RAs': [237, 321], 'contraindicated': [239], 'will': [244, 337], 'not': [245], 'benefit': [246], 'loss.': [249], 'Treatment': [250], 'benefits': [251], 'common': [252], 'all': [254], 'incretin-based': [255], 'hypoglycaemia': [259], 'risk,': [260], 'potential': [261], 'preservation': [262], 'function': [265], 'effective': [267], 'targeting': [268], 'multiple': [270], 'organs': [271], 'underlying': [272], 'diabetes': [275], 'comorbidities': [278], 'commonly': [279], 'diabetes,': [284], 'obesity': [287], 'hypertension.': [289], 'new': [292], 'Conclusion:': [294], 'Key': [295], 'differences': [296, 329], 'action': [300], 'extra-glycaemic': [305], 'treatment': [306], 'outcomes': [307], 'exist': [308], 'therapies,': [311], 'both': [312], 'within': [313], 'RA': [316], 'class,': [317], 'between': [319], 'inhibitors.': [324], 'Clinical': [325], 'judgment': [326], 'acknowledging': [327], 'important': [328], 'treatment-related': [334], 'characteristics': [336], 'appropriate': [344], 'agent': [346], 'pharmacotherapy.': [349]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1919558603', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 4}, {'year': 2017, 'cited_by_count': 7}, {'year': 2015, 'cited_by_count': 3}, {'year': 2014, 'cited_by_count': 9}, {'year': 2013, 'cited_by_count': 9}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-11T21:55:55.712596', 'created_date': '2016-06-24'}